[클리니컬 히스토리] 종근당 GERD 투트랙, 미니제형으로 브랜드 보강

Chong Kun Dang's launch of Esoduo Mini highlights a strategic shift to strengthen its proprietary GERD portfolio and improve profitability alongside high-volume licensed-in products. By prioritizing patient compliance through a miniaturized formulation, the company aims to sustain brand loyalty and counteract the rising market dominance of P-CAB-based treatments.